Cardiovascular comorbidities of pediatric psoriasis among hospitalized children in the United States - 23/11/17
Abstract |
Background |
Psoriasis has been shown to be associated with cardiovascular disease in adults. Little is known about cardiovascular risk in pediatric psoriasis.
Objective |
To determine if there is an association between pediatric psoriasis and cardiovascular comorbidities.
Methods |
Data were analyzed from the 2002-2012 Nationwide Inpatient Sample, which included 4,884,448 hospitalized children aged 0-17 years. Bivariate and multivariate survey logistic regression models were created to calculate the odds of psoriasis on cardiovascular comorbidities.
Results |
In multivariate survey logistic regression models adjusting for age, sex, and race/ethnicity, pediatric psoriasis was significantly associated with 5 of 10 cardiovascular comorbidities (adjusted odds ratio [95% confidence interval]), including obesity (3.15 [2.46-4.05]), hypertension (2.63 [1.93-3.59]), diabetes (2.90 [1.90-4.42]), arrhythmia (1.39 [1.02-1.88]), and valvular heart disease (1.90 [1.07-3.37]). The highest odds of cardiovascular risk factors occurred in blacks and Hispanics and children ages 0-9 years, but there were no sex differences.
Limitations |
The study was limited to hospitalized children. We were unable to assess the impact of psoriasis treatment or family history on cardiovascular risk.
Conclusion |
Pediatric psoriasis is associated with higher odds of multiple cardiovascular comorbidities among hospitalized patients. Strategies for mitigating excess cardiovascular risk in pediatric psoriasis need to be determined.
Le texte complet de cet article est disponible en PDF.Key words : arrhythmia, cardiovascular risk factors, comorbidities, diabetes, hyperlipidemia, hypertension, obesity, psoriasis, racial differences
Abbreviations used : ICD-9-CM, NIS
Plan
| Funding sources: Supported by the Agency for Healthcare Research and Quality, grant number K12 HS023011, and the Dermatology Foundation. |
|
| Conflicts of interest: None declared. |
Vol 77 - N° 6
P. 1023-1029 - décembre 2017 Retour au numéro
Article précédent
- Join the JAAD Virtual Journal Club to discuss this month's CME articles
- Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials
- Kenneth B. Gordon, Keith A. Betts, Murali Sundaram, James E. Signorovitch, Junlong Li, Meng Xie, Eric Q. Wu, Martin M. Okun
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?